We just celebrated the year-and-a-half anniversary of the launch of Private Briefing, and we've got a lot to be happy about. We've recommended as many as 66 winners - including two triples, three doubles and five takeovers.

Some of our biggest winners - and their peak gains - include:

• Pharmacyclics Inc. (Nasdaq: PCYC), up 222%
• Galapagos NV (PINK ADR: GLPYY), 205%.
• NQ Mobile (NYSE ADR: NQ), 153%.
• Sandstorm Inc. (TSE: SSL), 142%.
• Celldex Therapeutics Inc. (Nasdaq: CLDX), 105%
• Valero Inc. (NYSE: VLO), 95%
• HollyFrontier Corp. (NYSE: HFC), 86%.
• American Railcar Industries Inc. (Nasdaq: ARII), 77%.
• Accuray Inc. (Nasdaq: ARAY), 72%
• Pentair Inc. (NYSE: PNR), 67%.
• CNH Global NV (NYSE ADR: CNH), 67%.
• Nexen Inc. (NYSE: NXY), 63% and 41% (we recommended it twice);
• CrossTex Energy Partners (NYSE: XTXI), 53%.
• Molycorp Inc. (NYSE: MCP), 50%
• ProShares UltraShort Yen (NYSE: YCS): 45%.
• Delcath Systems Inc. (Nasdaq: DCTH), 42%.
• Oiltanking Partners LP (NYSE: OILT), 41%.
• NXP Semiconductors Inc. (NYSE ADR: NXTI): 41%
• U.S. Gasoline Fund (NYSE: UGA), 39%.
• eBay Inc. (Nasdaq: EBAY), 39%.

And we've done more than provide stock tips. Our experts have provided answers to your toughest questions, and we've detailed cutting-edge investment strategies for you. We've provided special research reports with winning picks in biotechnology, mining and digital technology. And we've provided insights about world events - the South China Sea affair and the Cyber-Hacking of America are just two of many - long before those stories hit the mainstream press.

To continue reading, please click here…